Detection of circulating antibodies to linear peptide antigens derived from ANXA1 and DDX53 in lung cancer

Tumor Biology

Volumn 35, Issue 5, 2014, Pages 4901-4905

  Wang, Weili ^a   Guan, Songlei ^b   Sun, Shilong ^a   Jin, Yonglong ^c   Lee, Kuang Hui ^d   Chen, Yubing ^c   Wei, Jun ^a,e  

^a JILIN UNIVERSITY   (China)

^b JILIN AGRICULTURAL UNIVERSITY   (China)

^c THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

^d Pei Ling Guan Si Hospital   (Taiwan)

^e UNIVERSITY OF THE HIGHLANDS AND ISLANDS   (United Kingdom)

Author keywords

ANXA1; Autoantibody; DDX53; Lung cancer; Tumor immunity

Indexed keywords

DEAD BOX PROTEIN; DEAD BOX PROTEIN 53; HLA ANTIGEN CLASS 2; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; LIPOCORTIN 1; UNCLASSIFIED DRUG; AUTOANTIBODY; DDX53 PROTEIN, HUMAN; TUMOR ANTIGEN;

ADULT; ANTIBODY DETECTION; ARTICLE; CANCER DIAGNOSIS; CANCER ELISA KIT; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HLA SYSTEM; HUMAN; HUMAN TISSUE; IMMUNOASSAY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; THORAX RADIOGRAPHY; AGED; BLOOD; IMMUNOLOGY; LUNG TUMOR;

AGED; ANNEXIN A1; ANTIGENS, NEOPLASM; AUTOANTIBODIES; CARCINOMA, NON-SMALL-CELL LUNG; DEAD-BOX RNA HELICASES; FEMALE; HUMANS; IMMUNOGLOBULIN G; LUNG NEOPLASMS; MALE; MIDDLE AGED;

EID: 84902959824     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-1643-4     Document Type: Article

References (26)

1. Reuschenbach M, von Knebel DM, Wentzensen N. A systematic review of humoral immune responses against tumor antigens. Cancer Immunol Immunother. 2009;58:1535-44.
2. Kobold S, Lütkens T, Cao Y, Bokemeyer C, Atanackovic D. Autoantibodies against tumor-related antigens: incidence and biologic significance. Hum Immunol. 2010;71:643-51.
3. Liu W, Peng B, Lu Y, Xu W, Qian W, Zhang J-Y. Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis. Autoimmun Rev. 2011;10:331-5.
4. Järås K, Anderson K. Autoantibodies in cancer: prognostic biomarkers and immune activation. Expert Rev Proteomics. 2011;8:577-89.
5. Piura E, Piura B. Autoantibodies to tumor-associated antigens in breast carcinoma. J Oncol. 2010;264926.
6. Piura E, Piura B. Autoantibodies to tailor-made panels of tumor-associated antigens in breast carcinoma. J Oncol. 2011;982425.
7. Zhong L, Coe SP, Stromberg AJ, Khattar NH, Jett JR, Hirschowitz EA. Profiling tumor-associated antibodies for early detection of non-small cell lung cancer. J Thorac Oncol. 2006;1:513-9. (Pubitemid 47181397)
8. Chapman C, Murray A, Chakrabarti J, Thorpe A, Woolston C, Sahin U, et al. Autoantibodies in breast cancer: their use as an aid to early diagnosis. Ann Oncol. 2007;18:868-73. (Pubitemid 47054083)
9. Tan HT, Low J, Lim SG, Chung MC. Serum autoantibodies as biomarkers for early cancer detection. FEBS J. 2009;276:6880-904.
10. Lam S, Boyle P, Healey GF, Maddison P, Peek L, Murray A, et al. EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancer. Cancer Prev Res (Phila). 2011;4:1126-34.
11. Chapman CJ, Healey GF, Murray A, Boyle P, Robertson C, Peek LJ, et al. EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays. Tumour Biol. 2012;33:1319-26.
12. Soussi T. TP53 mutations in human cancer: database reassessment and prospects for the next decade. Adv Cancer Res. 2011;110:107-39.
13. Chen YT, Scanlan MJ, Sahin U, Türeci O, Gure AO, Tsang S, et al. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA. 1997;94:1914-8. (Pubitemid 27113936)
14. Schubert U, Antón LC, Gibbs J, Norbury CC, Yewdell JW, Bennink JR. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature. 2000;404:770-4. (Pubitemid 30212405)
15. Ulanet DB, Torbenson M, Dang CV, Casciola-Rosen L, Rosen A. Unique conformation of cancer autoantigen B23 in hepatoma: a mechanism for specificity in the autoimmune response. Proc Natl Acad Sci USA. 2003;100:12361-6. (Pubitemid 37271565)
16. Liu L, Liu N, Liu B, Yang Y, Zhang Q, Zhang W, et al. Are circulating autoantibodies to ABCC3 transporter a potential biomarker for lung cancer? J Cancer Res Clin Oncol. 2012;138:1737-42.
17. Ye L, Li X, Sun S, Guan S, Wang M, Guan X, et al. A study of circulating anti-CD25 antibodies in non-small cell lung cancer. Clin Transl Oncol. 2013;5:633-7.
18. Zhang C, Ye L, Guan S, Jin S, Wang W, Sun S, et al. Autoantibodies against p16 protein-derived peptides may be a potential biomarker for non-small cell lung cancer. Tumour Biol. 2013. doi:10.1007/s13277-013-1271-4.
19. Guan S, Liu B, Zhang C, Lee K-H, Sun S, Wei J. Circulating autoantibody to CD25 may be a potential biomarker for early diagnosis of esophageal squamous cell carcinoma. Clin Transl Oncol. 2013;15:825-9.
20. Ye L, Guan S, Zhang C, Lee K-H, Sun L, Wei J, et al. Circulating autoantibody to FOXP3 may be a potential biomarker for esophageal squamous cell carcinoma. Tumour Biol. 2013;34:1873-7.
21. Söllner J, Heinzel A, Summer G, Fechete R, Stipkovits L, Szathmary S, et al. Concept and application of a computational vaccinology workflow. Immunome Res. 2010;6 Suppl 2:S7.
22. Wang P, Sidney J, Kim Y, Sette A, Lund O, Nielsen M, et al. Peptide binding predictions for HLA DR, DP and DQ molecules. BMC Bioinformatics. 2010;11:568.
23. Mayerhofer K, Tempfer C, Kucera E, Hefler L, Zeisler H, Kainz C, et al. Humoral p53 antibody response is a prognostic parameter in ovarian cancer. Anticancer Res. 1999;19(1B):875-8. (Pubitemid 29168348)
24. Abendstein B, Daxenbichler G, Windbichler G, Zeimet AG, Geurts A, Sweep F, et al. Predictive value of uPA, PAI-1, HER-2 and VEGF in the serum of ovarian cancer patients. Anticancer Res. 2000;20(1B):569-72. (Pubitemid 30189723)
25. Goodell V, Salazar LG, Urban N, Drescher CW, Gray H, Swensen RE, et al. Antibody immunity to the p53 oncogenic protein is a prognostic indicator in ovarian cancer. J Clin Oncol. 2006;24:762-8. (Pubitemid 46622043)
26. Anderson KS, Wong J, Vitonis A, Crum CP, Sluss PM, Labaer J, et al. p53 autoantibodies as potential detection and prognostic biomarkers in serous ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2010;19:859-68.